Riskpilot← Back to searchSign inGet full accessGEILO KVANTEKLINIKK AS
ASActiveOrg 915303331Øvre Lien 18, 3580 GeiloOther human health activities n.e.c. · NACE 8699Est. 20151 employees
Revenue 2025
NOK 563K
+101% vs 2024
EBITDA margin
3.3%
-74% vs 2024
Equity ratio
-1.0%
Financial strength
Net profit 2025
NOK 529
-99% vs 2024
| Revenue | NOK 563K | +101% |
| EBITDA | NOK 19K | -74% |
| Net profit | NOK 529 | -99% |
| Total assets | NOK 135K | +6% |
| Equity | NOK -1K | +28% |
| Employees | 1 | — |
Legal name
GEILO KVANTEKLINIKK AS
Org number
915303331
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
27. april 2015
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Drift av klinikk innenfor alternativ medisin, kjøp og salg, forvaltning av fast eiendom, deltagelse i andre selskap og hva som dermed står i forbindelse.
Address
Øvre Lien 18, 3580 Geilo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 507 | 577 | 405 | 281 | 563 |
| Staff expenses | −537 | −524 | −369 | −186 | −480 |
| EBITDA | −80 | −25 | 14 | 72 | 19 |
| Depreciation & amort. | −7 | −6 | −5 | −10 | −18 |
| EBIT | −88 | −31 | 9 | 62 | 1 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | −88 | −31 | 9 | 62 | 1 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −88 | −31 | 9 | 62 | 1 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 57 | 78 | 29 | 127 | 135 |
| Equity | −41 | −72 | −63 | −2 | −1 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 98 | 150 | 92 | 129 | 136 |
| Total debt | 98 | 150 | 92 | 129 | 136 |
EBITDA margin
3.3%
This company
15.8%
Market median
-79% vs market
20212025
Equity ratio
-1.0%
This company
38.2%
Market median
-103% vs market
20212025
Return on equity
52900.0%
This company
18.4%
Market median
+287400% vs market
20212025
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20212025
Asset turnover
4.17×
This company
1.12×
Market median
+272% vs market
20212025
Debt / equity
98.97×
This company
0.62×
Market median
-15863% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JE Deputy Member | Deputy Member | 2020 |
| Former (2) | ||
MB Accountant | Accountant | 2017 – 2023 |
MB Accountant | Accountant | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GEILO KVANTEKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| May Britt Solhaug | Accountant | 0 companies |
| May Britt Solhaug Junger | Accountant | 0 companies |
| Jan Egil Eriksen | Deputy Member | 0 companies |
| Heidi Pukerud | Chairman | 0 companies |